Carole Sable

Carole A. Sable is currently an Independent Non-Executive Director at Basilea Pharmaceutica AG since 2023.
Former positions include Executive Director-Clinical Research at Merck & Co., Inc. from 1995 to 2007, Vice President at Merck & Co., Inc. from 2010 to 2013, Chief Medical Officer at Vitae Pharmaceuticals LLC in 2016, Assistant Professor at the University of Virginia from 1993 to 1995, Chief Medical Officer at SCYNEXIS, Inc. from 2014 to 2015, Chief Medical Officer at Novexel SA from 2009 to 2010, Head-Clinical Development at Antabio SAS from 2018 to 2021, and Chief Medical Officer at Revolution Medicines, Inc. from 2015 to 2016.
Education includes a doctorate from Thomas Jefferson University, a doctorate from Sidney Kimmel Medical College conferred in 1983, and an undergraduate degree from the University of Scranton.